|
|
|
|
Extreme Heat Causes Major Health Problems For Older Adults
As we prepare for hotter, humid weeks ahead and temperatures reach well over 100 degrees in some parts of the country, older adults are at higher risk of health problems if they don't take the proper precautions to protect themselves from...
|
|
|
Decompensating esophoria as the presenting feature of myasthenia gravis
(Click the title below to leave the MDLinx Network and go to the Journal's Website) Journal of American Association for Pediatric Ophthalmology and Strabismus , 07/01/09 Arblaster GE et al.- This results in impairment of muscular...
|
|
|
Goldman Sachs Tells Clients To Buy Biogen Idec (BIIB) on Today's Weakness
Goldman Sachs is out in defense of Biogen Idec Inc.(Nasdaq: BIIB) on today's weakness due to the 10th PML case and a competitor (Deutsche Bank) downgrade. Shares of Biogen Idec are down 6.8% today on the PML disclosure and downgrade,...
|
|
|
In the know: AstraZeneca; GW Pharmaceuticals; Fiberweb
Weakness in gilts continued for a second day after the Bank of England said it was reviewing its gilt buyback programme, triggering fears that quantitative easing may soon be over.Ten-year gilt yields lost one basis point to 3.72...
|
|
|
Stoicism is no match for cancer
I'm not surprised to read that cancer survival rates in the over-75s are not improving in the same way that survival rates in younger people are.The majority of patients over 75 who come into my GP surgery open with 'I'm sorry to bother...
|
|
|
Apple, Merck, Kodak in focus
stock futures pointed lower for Wall Street on Monday, as traders searched for a spark to keep a rally from March lows alive.See Indications Global markets Weakness in oil producers led European shares lower Monday as crude prices...
|
|
|
Baird Is a Buyer of BioMarin (BMRN) On Genzyme-Related Weakness
Baird said they are buyers of BioMarin Pharmaceutical Inc.(Nasdaq: BMRN) on weakness tied to Genzyme Corp. (Nasdaq: GENZ) Allston manufacturing suspension. The firm notes, 'Aldurazyme fill/finish was previously performed at this...
|
|
|
Monsanto: Controversial but Profitable
Below is a good look at the always controversial Monsanto (MON) from the CEO's chair.Timely considering the company warned on the quarter last week [May 27, 2009: Monsanto Pulls Full Year Earnings Guidance Down to Lower End on Roundup ...
|
|
|
The 20 Cancer Symptoms Women Are Most Likely to Ignore
Don't rely on routine tests alone to protect you from cancer.It's just as important to listen to your body and notice anything that's different, odd, or unexplainable. Here are some signs that are commonly overlooked: 1. Wheezing or...
|
|
|
Monsanto Slashes 3Q EPS View On Roundup Weakness
DOW JONES NEWSWIRES Monsanto Co.(MON) said the weather and competition are pressuring its Roundup herbicide operations as the agribusiness giant sees earnings for the year at the lower end of its forecast.It also projected a profit for...
|
|
|
Monsanto Slashes 3Q EPS View On Roundup Weakness (DJ)
DOW JONES NEWSWIRES Monsanto Co.(MON) said the weather and competition are pressuring its Roundup herbicide operations as the agribusiness giant sees earnings for the year at the lower end of its forecast. It also projected a profit for...
|
|
|
Monsanto Slashes 3Q EPS View On Roundup Weakness
DOW JONES NEWSWIRES Monsanto Co.(MON) said the weather and competition are pressuring its Roundup herbicide operations as the agribusiness giant sees earnings for the year at the lower end of its forecast. It also projected a profit for...
|
|
|
Weak hips may lead to runners' lower-leg injuries
-0400 (Reuters Health) By Amy Norton NEW YORK (Reuters Health) - Weakness in the muscles that support the hips may be a common contributor to many overuse injuries in runners, a new research review suggests.For most runners, overuse...
|
